Where it is registered
Each register with its number of medicines and a few of them.
All medicines with Vaccine, recombinant
Every register, a page at a time. Strengths and packs are on each medicine’s page.
75 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| CervarixCombination | United States | 0.5ML | Injection | Not marketed | GlaxoSmithKline Biologicals |
| GardasilCombination | United States | 120MCG L1 PROTEIN FROM HPV 6, 11, 16 AND 18 UG/.5ML | Injection | Not marketed | Merck Sharp & Dohme LLC |
| Recombivax, Recombivax Hb | United States | 10UG/ML | Injection | Marketed | Merck Sharp & Dohme LLC |
| Recombivax, Recombivax Hb | United States | 5UG/0.5ML | Injection | Marketed | Merck Sharp & Dohme LLC |
| Recombivax, Recombivax Hb | United States | 10UG/ML | Injection | Marketed | Merck Sharp & Dohme LLC |
| Recombivax, Recombivax Hb | United States | 40UG/ML | Injection | Marketed | Merck Sharp & Dohme LLC |
| Recombivax, Recombivax Hb | United States | 5UG/0.5ML | Injection | Marketed | Merck Sharp & Dohme LLC |
| Gardasil Recombinant VaccineCombination | Saudi Arabia | Authorised | Merck Sharp and Dohme LLC | ||
| NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 µg/dose (RECOMBINANT, ADJUVANTED) | Singapore | 5 µg/dose | injection, suspension | Authorised | Sanofi-Aventis Singapore Pte. LTD. |
| Nuvaxovid Dispersion for Injection COVID19 Vaccine 5mcg/dose (recombinant, adjuvanted) in PFS | Singapore | 5 mcg/0.5ml | injection, suspension | Authorised | Sanofi-Aventis Singapore Pte. LTD. |
| NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 mcg/dose (RECOMBINANT, ADJUVANTED) IN SDV | Singapore | 5 mcg/dose | injection, suspension | Authorised | Sanofi-Aventis Singapore Pte. LTD. |
| Vimkunya | United States | 40UG/0.8ML | Injection | Marketed | Bavarian Nordic A/S |
| Engerix-B | United States | 10UG/.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| Engerix-B | United States | 10UG/.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| Engerix-B | United States | 20UG/ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| Engerix-B | United States | 20UG/ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| Gardasil 9 | United States | 0.5ML | Injection | Marketed | Merck Sharp & Dohme LLC |
| Gardasil 9 | United States | 0.5ML | Injection | Marketed | Merck Sharp & Dohme LLC |
| Heplisav-B | United States | 20UG/.5ML | Injection | Marketed | Dynavax Technologies Corporation |
| PediarixCombination | United States | 0.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| Shingrix | United States | 0.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| Shingrix | United States | 50UG | Injection | Marketed | GlaxoSmithKline Biologicals |
| Shingrix | United States | 50UG | For Injection | Marketed | GlaxoSmithKline Biologicals |
| Twinrix | United States | 1ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| Shingrix | Canada | 50 MCG / 0.5 ML | Suspension | Marketed | Glaxosmithkline INC |
Brand names
The same brand on several registers.
Companies
The companies holding its medicines, the most first.
Sources
Compiled by Prognia from the public medicine registers of FDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 1
- Medicines
- 2
- Companies
- 2